Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute is a clinical research site located in Seattle, Washington, United States 98104.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis.
Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.